Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2
出版年份 2020 全文链接
标题
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2
作者
关键词
-
出版物
HEADACHE
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-12-14
DOI
10.1111/head.14036
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1)
- (2020) Messoud Ashina et al. CEPHALALGIA
- European Academy of Neurology guideline on the management of medication‐overuse headache
- (2020) H. C. Diener et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy and safety of eptinezumab in patients with chronic migraine
- (2020) Richard B. Lipton et al. NEUROLOGY
- Complete withdrawal is the most effective approach to reduce disability in patients with medication-overuse headache: A randomized controlled open-label trial
- (2019) Mia Nielsen et al. CEPHALALGIA
- Erenumab in chronic migraine
- (2019) Richard B. Lipton et al. NEUROLOGY
- Erenumab in chronic migraine with medication overuse
- (2019) Stewart J. Tepper et al. NEUROLOGY
- Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial
- (2019) David W Dodick et al. CEPHALALGIA
- Pathophysiology, prevention, and treatment of medication overuse headache
- (2019) Hans-Christoph Diener et al. LANCET NEUROLOGY
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
- (2018) Andrew M. Blumenfeld et al. JOURNAL OF HEADACHE AND PAIN
- Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study
- (2018) Todd J. Schwedt et al. JOURNAL OF HEADACHE AND PAIN
- A Systems Neuroscience Approach to Migraine
- (2018) K.C. Brennan et al. NEURON
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Spencer L James et al. LANCET
- Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants
- (2017) Yohannes W. Woldeamanuel et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Health and quality of life in patients with medication overuse headache syndrome after standardized inpatient rehabilitation
- (2017) Thomas Benz et al. MEDICINE
- Long-term Treatment Benefits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
- (2017) Simona Guerzoni et al. Frontiers in Neurology
- Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study
- (2016) Myoung-Jin Cha et al. Journal of Clinical Neurology
- Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study
- (2016) Ninett Louise Find et al. JOURNAL OF HEADACHE AND PAIN
- Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
- (2015) Andrew F. Russo Annual Review of Pharmacology and Toxicology
- Clinical and Demographical Characteristics of Patients with Medication Overuse Headache in Argentina and Chile: Analysis of the Latin American Section of COMOESTAS Project
- (2015) Beatriz Shand et al. JOURNAL OF HEADACHE AND PAIN
- OnabotulinumtoxinA 155 U in medication overuse headache: a two years prospective study
- (2015) Andrea Negro et al. SpringerPlus
- Medication-overuse headache: a review
- (2014) Espen Saxhaug Kristoffersen et al. Journal of Pain Research
- Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review
- (2013) Maria L Westergaard et al. CEPHALALGIA
- The International Classification of Headache Disorders, 3rd edition (beta version)
- (2013) CEPHALALGIA
- Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project)
- (2013) L Bendtsen et al. CEPHALALGIA
- OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline
- (2013) Stephen D. Silberstein et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- The cost of headache disorders in Europe: the Eurolight project
- (2011) M. Linde et al. EUROPEAN JOURNAL OF NEUROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started